Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 18, 1997

View Archived Issues

Ortho synthesizes inhibitors of serine proteases

COR Therapeutics discloses factor Xa inhibitors

Abbott discloses nicotinic cholinergic channel modulators

Adenosine kinase inhibitors prepared by Gensia

Immunosuppressants discovered by Merck & Co.

Yeda discloses peptides for myasthenia gravis

Inhibitors of cell adhesion disclosed by Tanabe

TCR peptides for MS reported by Connective Therapeutics

Progen's lead compound shows promise for cancer/metastasis

Japanese introduction for new formulation of epoetin alfa

Ibustrin for diabetic vascular complications

Mechanism of antitumor effect of natural lipopolysaccharide

AD diagnostic reaches market

Aphton and Pasteur Merieux Connaught form immunotherapy product alliance

AEterna clarifies Neovastat clinical development program

New dosage strengths of Coumadin available

Antidepressant with minimal impact on sexual function introduced

Immunomedics' LeukoScan approved for European market

Bard presents new bladder cancer diagnostic test

Peptide Therapeutics/SmithKline Beecham vaccine technology alliance

MedImmune's HPV vaccine enters phase I

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...